Skip to content

Clinical trials

Phase 3 Heart Failure trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Singapore Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20143
20171
20181
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Boehringer Ingelheim1
Boston Scientific Corporation1
CSL Behring1
Novo Nordisk A/S1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Scios, Inc.1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure11
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Fibrillation1
Bundle-Branch Block1
Cardiovascular Diseases1
Coronary Artery Disease1
Death1
Dyspnea1
Heart Diseases1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.